ChatGPT Ads for dermatology clinics.

Your two halves face opposite constraints

A patient worried about a changing mole opens an assistant and describes it. That is a personal-diagnosis conversation, and OpenAI keeps sensitive conversations ad-free even for approved advertisers. No amount of budget puts you in front of that person at that moment.

Someone weighing up a cosmetic treatment asks what it involves, how long results last and what it should cost. That is a commercial conversation, and it is the half of your practice where a placement can realistically appear.

This is the reverse of how most clinics think about the two sides. Medical work is usually the higher-intent, easier sell. Here it is the half the channel is structurally closed to.

Eligibility is the less certain half of the question

In May 2026 healthcare, prescription drugs and clinical care providers were excluded from ad inventory outright, with dermatology named among the prohibited categories. By August 2026 reporting described healthcare approval as case by case with manual review, naming dental services, vision products, medical testing and hospitals among those approved. Dermatology was not among the named approvals.

That is not the same as prohibited. It means we could not find it confirmed, and given the policy has changed four times in five months we will check the current position before you commit anything.

Prescription-only treatments carry their own layer. If the campaign touches products that are prescription-only in your market, expect that to be assessed on its own terms regardless of how your category is classified.

The advertising rules do not soften on a new surface

If you advertise higher-risk cosmetic procedures in Australia, AHPRA's guidelines follow you here. Their definition of advertising is broad enough to include directory listings, so a conversational ad placement is comfortably inside it.

That means the testimonial position applies, the requirement to include a practitioner registration number where a named individual is referenced applies, and the constraints on before-and-after imagery apply.

A conversational surface is, if anything, riskier for this. The copy is written in plain, reassuring language, which is exactly the register that produces an implied outcome claim without anyone intending one.

What we could not verify, and why that matters

OpenAI's own ad policies page returns a 403 to our tooling, so the eligibility position above is secondary reporting and dated accordingly.

The AHPRA position is not. It comes from the regulator's own guidelines and applies regardless of what any platform permits. Approval to advertise is not permission to say something your regulator prohibits.

What we do on a dermatology ChatGPT Ads account

• An eligibility and market check against the current policy before you spend anything
• Medical and cosmetic assessed separately, because they face opposite placement constraints
• A recommendation against spending on the medical side while the restriction holds
• All copy checked against the cosmetic advertising guidelines that apply to you
• Context descriptions written from commercial questions rather than symptom descriptions
• Registration number requirements handled where a named practitioner is referenced
• Monthly reporting with the policy position re-checked and re-dated each time

Questions

Sources

• Search Engine Journal — OpenAI allows some health and finance ads
• AHPRA — Cosmetic procedure advertising guidelines
• OpenAI — Ad policies

Guides for dermatologists